HOME >> BIOLOGY >> NEWS
Drug prevents chemotherapy-induced hearing loss, study finds

PORTLAND, Ore. -- A drug used to treat people with Tylenol poisoning prevents hearing loss caused by a common chemotherapy drug, an Oregon Health & Science University study reports.

The study published in the journal Hearing Research found that rats treated with N-acetylcysteine, or NAC, did not suffer from platinum-induced ototoxicity, or hearing loss, caused by a widely used chemotherapeutic agent known as cisplatin.

Cisplatin, or CDDP, is a platinum-based compound used in chemotherapy for head and neck cancer. But it causes progressive, irreversible hearing loss, reducing patients' quality of life and forcing doctors to use lower, less-effective doses of the drug.

"It affects about a third of all children with cancer in the United States, not just those with brain tumors," said study co-author Edward Neuwelt, M.D., professor of neurology and neurological surgery, OHSU School of Medicine, and the Portland Veterans Affairs Medical Center. He also directs OHSU's Blood-Brain Barrier Program. "It's a big problem."

The study's lead author, D. Thomas Dickey, D.V.M., research instructor in neurology, OHSU School of Medicine, called ototoxicity "one of the main dose-limiting factors in giving cisplatin."

"Cisplatin is given a lot. It's been around a long time, and it's very effective. But it's very toxic," Dickey said.

Cisplatin is administered intravenously to slow or stop the growth of cancer cells. In addition to head and neck cancers, the drug is used to treat cervical carcinoma, lung cancer, neurologic cancers and a wide variety of other malignancies. But it injures hair cells of the cochlea, the spiral, inner-ear structure containing thousands of tiny hair cells that vibrate in response to sound waves.

"These hair cells are often destroyed," Dickey said. "It starts at the outer edge and moves in. Once it happens, it's progressive -- it gets worse and worse -- and it's permanent."

Hearing aids aren't as
'"/>

Contact: Jonathan Modie
modiej@ohsu.edu
503-494-8231
Oregon Health & Science University
20-Jul-2004


Page: 1 2 3

Related biology news :

1. Lack of immune system protein prevents lupus-like condition in mice
2. Combination of gene therapy and gene silencing prevents neurodegenerative disease
3. Pacifying bacteria prevents lethal post-op infections
4. Investigational cancer drug prevents abnormal brain growth, reverses seizures in lab mice
5. Hopkins researchers discover how nitric oxide prevents blood vessel inflammation
6. Injection prevents blinding blood vessel growth in mice
7. Tiny protein prevents disease-related cell death
8. Smart mathematical model prevents the spread of swine fever
9. Aspirin prevents polyps in colon cancer patients
10. Twin sister mechanism prevents formation of genetic mutations
11. Vaccine prevents stroke in rats

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. ... with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. ... supply chain for more than 10 years. Early in the COVID-19 crisis, we ...
(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a critical stage ... a COVID cure or vaccine, the global economic downturn will only increase price pressures ... going away and capturing full value from every product launch is critical. However, history ...
(Date:7/2/2020)... FREDERICK, Md. (PRWEB) , ... ... ... company, Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the ... a one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign ... detection and prevention of high-burden diseases, and Centric Consulting, a business and technology ... to utilize existing data in order to identify and prioritize patients for care. ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Institute of Technology (MIT) has expanded the company’s exclusive license to include ... into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering ... to 200 million stem cells. Depending on the patient's condition, treatment may be offered ... will die having some form of Alzheimers dementia, and the incidence continues to increase ...
(Date:7/1/2020)... ... June 29, 2020 , ... The Interlocal Purchasing System (TIPS), ... membership, recently named BioFit Engineered Products an Awarded Vendor. Awarded Vendor ... seating, cafeteria tables, book trucks and carts at discounted pricing without the delay ...
Breaking Biology Technology:
Cached News: